← Product Code [KPS](/productcode/KPS) · K082354 # STEREO NAVIGATOR ACCESSORY, STN-1000 (K082354) _Naviscan Pet Systems · KPS · Nov 18, 2008 · Radiology · SESE_ **Canonical URL:** https://fda.innolitics.com/device/K082354 ## Device Facts - **Applicant:** Naviscan Pet Systems - **Product Code:** [KPS](/productcode/KPS.md) - **Decision Date:** Nov 18, 2008 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 892.1200 - **Device Class:** Class 2 - **Review Panel:** Radiology ## Indications for Use The Stereo Navigator Accessory is an optional accessory to the PEM Flex® PET Scanner. It is intended for the localization of lesions in female breasts, as identified on a PET image. By using the Stereo Navigator, the physician is able to guide compatible interventional devices towards the PET abnormality as medically indicated. The Stereo Navigator also provides a means to confirm localization of the lesion in advance of the interventional procedure. ## Device Story Stereo Navigator Accessory functions as an optional add-on for PEM Flex PET Scanner; assists physicians in breast lesion localization. Input: PET tomographic images (2D planar slices). Operation: User defines target on two orthogonal images; software processes coordinates into 3D stereotactic data; guides positioning of stereotactic frame for interventional device trajectory and insertion depth. Verification: Encapsulated positron-emitting line source inserted through cannula to target site; image acquired to confirm alignment relative to lesion. Output: Stereotactic coordinates and visual confirmation of device placement. Clinical benefit: Enables precise guidance of interventional tools to PET-identified abnormalities; facilitates accurate sampling or marking. ## Clinical Evidence Preclinical (phantom) studies and confirmatory clinical studies performed. Data demonstrated device is as safe and effective as predicate devices. ## Technological Characteristics Accessory for PEM Flex PET Scanner; determines 3D coordinates from 2D orthogonal PET image slices. Utilizes software to process stereotactic frame positioning and insertion depth. Includes encapsulated positron-emitting line source for verification. No specific materials or software architecture details provided. ## Regulatory Identification An emission computed tomography system is a device intended to detect the location and distribution of gamma ray- and positron-emitting radionuclides in the body and produce cross-sectional images through computer reconstruction of the data. This generic type of device may include signal analysis and display equipment, patient and equipment supports, radionuclide anatomical markers, component parts, and accessories. ## Predicate Devices - Stereotactic Localization Device (SLD), Philips Medical Systems - Confirma Breast MRI Interventional Components, Confirma, Inc - SureLoc® CADstream 4.0 System, Confirma, Inc. ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ K082354 NOV 1 8 2008 Image /page/0/Picture/2 description: The image shows the word "NAVISCAN" in a bold, sans-serif font. There is a curved line above the word that starts from the left and extends over the "N". The letters are all capitalized and evenly spaced. The overall design is simple and modern. Naviscan, Inc. 11180 Roselle Street, Suite 100 San Diego, CA 92121 +1.858.587.3641 Direct +1.858.587.2596 Fax www.naviscan.com # 510(k) SUMMARY As required by section 807.92(c) ## Naviscan, Inc.'s Stereotactic Navigation Accessory Stereo Navigator Accessory for the PEM Flex® PET Scanner | Company Name: | Naviscan, Inc. | |----------------------|-----------------------------------------------------------------| | Address: | 11180 Roselle Street, Suite 100 | | | San Diego, CA 92121 | | Contact Person: | Heather Jalisi | | Phone: | 858.332.0942 | | Fax: | 858.857.2596 | | Date Prepared: | August 12, 2008 | | Trade name: | Stereo Navigator Accessory for the PEM Flex® PET Scanner | | Classification Name: | Accessory to Emission Computed Tomography System | | | 21 CFR 892.1200, Product Code 90-KPS, Device Class II | | Predicate Devices: | Stereotactic Localization Device (SLD), Philips Medical Systems | | | Confirma Breast MRI Interventional Components, Confirma, Inc | | | SureLoc® CADstream 4.0 System, Confirma, Inc. | {1}------------------------------------------------ Intended Use / Indications for Use: The Stereo Navigator Accessory is an optional accessory to the PEM FIcx® PET Scanner. It is intended for the localization of lesions in female breasts, as identified on a PET image. By using the Stereo Navigator, the physician is able to guide compatible interventional devices towards the PET abnormality as medically indicated. The Stereo Navigator also provides a means to confirm localization of the lesion in advance of the interventional procedure. Technological Characteristics: The Stereo Navigator determines the three dimensional coordinates of a userdefined target for an imaged abnormality (e.g. lesion) displayed on the PEM Flex PET Scanner. Since PEM Flex tomographic images are displayed as a series of 2D planar slices, the user must define a target on two orthogonal images to define all three axis coordinates of the target location. These coordinates are processed into stereotactic information by the Stereo Navigator software which is used by the healthcare provider to position a stereotactic frame for guiding the trajectory of an interventional device and for determining the depth to which the interventional device should be inserted along the trajectory. Additionally, the Stereo Navigator provides a means for the user to confirm that localization has been achieved during the interventional procedure and prior to sampling or marking. This is accomplished by placing an encapsulated positronemitting line source (radioactive line source) through the tissue access port (cannula) of the interventional device to the intended sampling or marking site, 6-3 {2}------------------------------------------------ 510(k) Summary, Stereo Navigator Accessory acquiring an image and comparing the location of the line source relative to the lesion (in at least two orthogonal image planes). Performance Data: The Stereo Navigator was subject to preclinical (phantom) studies and confirmatory clinical studies. These studies demonstrated that the device is substantially equivalent to the predicates with respect to safety and effectiveness. Substantial Equivalence: The Stereo Navigator is as safe and effective as the 1) Stereotactic Localization Device (SLD), 2) Confirma Breast MRI Interventional Components, and 3) SureLoc® CADstream 4.0 System, ("Predicate Devices"). The Stereo Navigator has the same intended uses and similar indications, technological characteristics, and principles of operation as its predicate devices. The minor technological differences between the Stereo Navigator and its predicate devices raise no new issues of safety or effectiveness. Performance data demonstrate that the Stereo Navigator is as safe and effective as the Predicate Devices. Thus, the Stereo Navigator is substantially equivalent. {3}------------------------------------------------ Image /page/3/Picture/0 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with three tail feathers, representing the department's mission to protect the health of all Americans and provide essential human services. The eagle is positioned to the right of the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA", which is arranged in a circular fashion around the eagle. ## DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 ### NOV 1 8 2008 Ms. Heather Jalisi Director, Quality and Regulatory Naviscan, Inc. 11180 Roselle Street, Suite 100 SAN DIEGO CA 92121 Re: K082354 Trade/Device Name: Stereo Navigator Accossory for the PEM Flex® PET Scanner Regulation Number: 21 CFR 892.1200 Regulation Name: Emission computed tomography system Regulatory Class: II Product Code: KPS Dated: August 12, 2008 Received: August 26, 2008 Dear Ms. Jalisi: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {4}------------------------------------------------ #### Page 2 Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at one of the following numbers, based on the regulation number at the top of this letter: | 21 CFR 876.xxx | (Gastroenterology/Renal/Urology) | 240-276-0115 | |----------------|----------------------------------|--------------| | 21 CFR 884.xxx | (Obstetrics/Gynecology) | 240-276-0115 | | 21 CFR 894.xxx | (Radiology) | 240-276-0120 | | Other | | 240-276-0100 | Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometrics' (OSB's) Division of Postmarket Surveillance at 240-276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at 240-276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html. Sincerely yours, loque M. Whang Joyce M. Whang, Ph.D. Acting Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {5}------------------------------------------------ #### Indications for Use Statement 510(k) Number (if known): Kod 2354 Device Name: Stereo Navigator Accessory for the PFM Flex® PET Scanner Indications for Use: The Stereo Navigator Accessory is an optional accessory to the PEM Flex® PET Scanner. It is intended for the localization of lesions in female breasts, as identified on a PET image. By using the Stereo Navigator, the physician is able to guide compatible interventional devices towards the PFT abnormality as medically indicated. The Stereo Navigator also provides a means to confirm localization of the lesion in advance of the interventional procedure. Prescription Use ______________ AND/OR Over-The-Counter Use (Part 21 CFR 801 Subpart D) (21 CFR 801 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE – CONTINUE ON ANOTHER PAGE IF NEEDED) | Concurrence of CDRH, Office of Device Evaluation (ODE) | |--------------------------------------------------------| |--------------------------------------------------------| (Division Sign-Off) Division of Reproductive, Abdominal and Radiological Devices 510(k) Number ર-Σ --- **Source:** [https://fda.innolitics.com/device/K082354](https://fda.innolitics.com/device/K082354) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com